Literature DB >> 10931443

Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies.

S E Blondelle1, K Lohner.   

Abstract

In the race for supremacy, microbes are sprinting ahead. This warning by the World Health Organization clearly demonstrates that the spread of antibiotic-resistant bacteria leads to a global health problem and that antibiotics never seen before by bacteria are urgently needed. Antimicrobial peptides represent such a source for novel antibiotics due to their rapid lytic activity (within minutes) through disruption of cell membranes. However, due to the similarities between bacterial, fungal, and mammalian plasma cell membranes, a large number of antimicrobial peptides have low lytic specificities and exhibit a broad activity spectrum and/or significant toxic effect toward mammalian cells. Mutation strategies have allowed the development of analogues of existing antimicrobial peptides having greater lytic specificities, although such methods are lengthy and would be more efficient if the molecular mechanisms of action of antimicrobial peptides were clearly elucidated. Synthetic combinatorial library approaches have brought a new dimension to the design of novel biologically active compounds. Thus, a set of peptide analogues were generated based on the screening of a library built around an existing lytic peptide, and on a deconvolution strategy directed toward activity specificity. These peptide analogues also served as model systems to further study the effect of biomembrane mimetic systems on the peptides structural behavior relevant to their biological activities. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931443     DOI: 10.1002/1097-0282(2000)55:1<74::AID-BIP70>3.0.CO;2-S

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  28 in total

1.  Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides.

Authors:  Dagmar Zweytick; Günter Deutsch; Jörg Andrä; Sylvie E Blondelle; Ekkehard Vollmer; Roman Jerala; Karl Lohner
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl.

Authors:  Hadar Sarig; Yair Goldfeder; Shahar Rotem; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides.

Authors:  Rafael Ferre; Esther Badosa; Lidia Feliu; Marta Planas; Emili Montesinos; Eduard Bardají
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

4.  High-throughput and facile assay of antimicrobial peptides using pH-controlled fluorescence resonance energy transfer.

Authors:  Young Soo Kim; Hyung Joon Cha
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

5.  Design and synthesis of biologically active peptides: a 'tail' of amino acids can modulate activity of synthetic cyclic peptides.

Authors:  Alberto Bryan; Leroy Joseph; James A Bennett; Herbert I Jacobson; Thomas T Andersen
Journal:  Peptides       Date:  2011-10-12       Impact factor: 3.750

6.  Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.

Authors:  Shahar Rotem; Inna Radzishevsky; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

7.  Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity.

Authors:  Shu-Yi Wei; Jiun-Ming Wu; Yen-Ya Kuo; Heng-Li Chen; Bak-Sau Yip; Shiou-Ru Tzeng; Jya-Wei Cheng
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

8.  Structure-activity studies and therapeutic potential of host defense peptides of human thrombin.

Authors:  Gopinath Kasetty; Praveen Papareddy; Martina Kalle; Victoria Rydengård; Matthias Mörgelin; Barbara Albiger; Martin Malmsten; Artur Schmidtchen
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

9.  Screening nonspecific interactions of peptides without background interference.

Authors:  Andrew J Keefe; Kyle B Caldwell; Ann K Nowinski; Andrew D White; Amit Thakkar; Shaoyi Jiang
Journal:  Biomaterials       Date:  2012-12-14       Impact factor: 12.479

10.  Antimicrobial characterization of human beta-defensin 3 derivatives.

Authors:  David M Hoover; Zhibin Wu; Kenneth Tucker; Wuyuan Lu; Jacek Lubkowski
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.